Sagar Doshi of Edelweiss Financial Services has a sell call on Ajanta Pharma with a target price of Rs 1,080.

The current market price of Ajanta Pharma is Rs 1,131.10.

Time period given by the analyst is intraday when Ajanta Pharma price can reach defined target.

Sagar Doshi recommended to keep a stop loss at Rs 1,165.

Ajanta Pharma, incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 9,954.36 Crore) operating in Pharmaceuticals and health care sector.

Ajanta Pharma key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 1,753.68 Crore to Sales Value (96.21 per cent of Total Sales), Textiles which contributed Rs 66.83 Crore to Sales Value (3.66 per cent of Total Sales) and Other Operating Revenue which contributed Rs 2.20 Crore to Sales Value (0.12 per cent of Total Sales)for the year ending 31-Mar-2017.

For the quarter ended 30-06-2017, the company has reported a Consolidated sales of Rs 473.12 Crore, up 3.73 per cent from last quarter Sales of Rs 456.12 Crore and up 4.16 per cent from last year same quarter Sales of Rs 454.21 Crore.

Company has reported net profit after tax of Rs 94.79 Crore in latest quarter.

The company's top management includes Dr.Anil Kumar, Dr.Anjana Grewal, Mr.Chandrakant M Khetan, Mr.K H Viswanathan, Mr.Madhusudan B Agrawal, Mr.Mannalal B Agrawal, Mr.Prabhakar Dalal, Mr.Purushottam B Agrawal, Mr.Rajesh M Agrawal, Mr.Yogesh M Agrawal.

Company has Kapoor & Parekh Associates as its auditors.

As on 30-06-2017, the company has a total of 88,006,000 shares outstanding.